Novel herbicide targeting lysine biosynthesis via the DAP pathway in weeds

Technology
Conceptual
University

A new herbicide mode of action targeting the diaminopimelate (DAP) lysine biosynthesis pathway exclusive to plants and bacteria. Includes MBDTA, the first dual-target herbicidal inhibitor, proven lethal to multiple weed species with no effects on mammalian cells or soil microbes. Seeking validation across grasses and crops.

Overview

This research program proposes a novel herbicide mode of action targeting lysine biosynthesis in weeds through inhibition of the diaminopimelate (DAP) pathway. Because the DAP pathway exists only in plants and bacteria, with animals unable to produce their own lysine, selective inhibition is unlikely to harm mammals or beneficial organisms. The program has developed inhibitors of multiple enzymes in the lysine biosynthesis pathway, including MBDTA, the first known dual-target herbicidal inhibitor. Proof-of-concept data demonstrates lethality against Arabidopsis thaliana, annual ryegrass (Lolium rigidum), and wild radish (Raphanus raphanistrum), with high specificity to plants and no observed effects on mammalian cells or soil microbes. The opportunity centers on validating these inhibitors across a broader range of grasses and crops to establish efficacy and selectivity.

Technical specifications
  • Target pathway: The diaminopimelate (DAP) pathway, responsible for lysine production exclusively in plants and bacteria
  • Lead compound: MBDTA, the first example of a dual-target herbicidal inhibitor acting on the lysine biosynthesis pathway
  • Inhibitor library: An array of inhibitors targeting multiple enzymes within the lysine biosynthesis pathway
  • Validated weed species: Arabidopsis thaliana, annual ryegrass (Lolium rigidum), and wild radish (Raphanus raphanistrum)
  • Selectivity profile: No effects observed on mammalian cells or soil microbes
  • Application modes: Pre-emergence and post-emergence treatment protocols
  • Synergy testing: Compatibility assessment with current commercial herbicides, including glyphosate
  • Crop tolerance assessment: Planned evaluation on rice, wheat, and other crops
  • Synthesis: Scaled-up compound production following established synthetic routes
Technology readiness level

The technology is at an advanced early-stage research and proof-of-concept level. Inhibitors of the lysine biosynthesis pathway have been developed and validated for lethality in multiple weed species. Selectivity testing has confirmed safety toward mammalian cells and soil microbes. The next phase involves greenhouse screening against a wider range of grasses to determine efficacy, and crop tolerance studies to establish selectivity. Combination studies with existing herbicides will assess synergistic potential. This validation work will advance the program toward field-ready herbicide candidates with a novel mode of action.


About The University of Adelaide

The University of Adelaide was a comprehensive public research university in South Australia, with a city‑centre campus and specialised sites linking teaching, research and translation. Co‑location within Adelaide BioMed City placed teams beside the Royal Adelaide Hospital and SAHMRI, enabling clinical trials, while AIML at Lot Fourteen linked researchers to an innovation district. At the Waite Research Precinct, co‑located partners and infrastructure such as the Plant Accelerator supported industry‑engaged R&D. Research was backed by national funding, including the Australian Research Council and NHMRC. On January 5, 2026 it merged with the University of South Australia to form Adelaide University; these assets now operate within the new institution with dedicated tech transfer support.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.